132 related articles for article (PubMed ID: 8741942)
1. Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats.
Dall'Olio R; Rimondini R; Gandolfi O
Psychopharmacology (Berl); 1996 Jan; 123(2):187-90. PubMed ID: 8741942
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
Starr MS; Starr BS
Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
[TBL] [Abstract][Full Text] [Related]
3. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
Dall'Olio R; Rimondini R; Gandolfi O
Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
[TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
5. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the serotonergic system counteracts the dizocilpine-induced changes in dopaminergic function.
Dall'Olio R; Gandolfi O; Gaggi R
Behav Pharmacol; 2000 Feb; 11(1):29-36. PubMed ID: 10821206
[TBL] [Abstract][Full Text] [Related]
7. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
Wedzony K; Czyrak A; Maćkowiak M; Fijał K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
[TBL] [Abstract][Full Text] [Related]
8. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
10. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
Dall'olio R; Rimondini R; Gandolfi O
Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.
Starr MS; Starr BS
Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652
[TBL] [Abstract][Full Text] [Related]
12. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Boldry RC; Chase TN; Engber TM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
[TBL] [Abstract][Full Text] [Related]
13. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801.
Goodwin P; Starr BS; Starr MS
J Neural Transm Park Dis Dement Sect; 1992; 4(1):15-26. PubMed ID: 1531757
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
Domino EF; Sheng J
J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
[TBL] [Abstract][Full Text] [Related]
15. Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse.
Kaur S; Starr MS; Starr BS
J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):107-16. PubMed ID: 7893372
[TBL] [Abstract][Full Text] [Related]
16. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance.
Mele A; Castellano C; Oliverio A
Psychopharmacology (Berl); 1995 Oct; 121(3):401-5. PubMed ID: 8584624
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.
Dall'Olio R; Gandolfi O; Montanaro N
Psychopharmacology (Berl); 1992; 107(4):591-4. PubMed ID: 1534911
[TBL] [Abstract][Full Text] [Related]
20. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
Paul ML; Currie RW; Robertson HA
Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
